CA Stock MarketDetailed Quotes
MGRO MustGrow Biologics Corp
- 1.840
- +0.120+6.98%
15min DelayPost Market Nov 28 15:59 ET
95.02MMarket Cap0.00P/E (TTM)
1.850High1.720Low21.61KVolume1.720Open1.720Pre Close38.84KTurnover2.53052wk High0.05%Turnover Ratio51.64MShares0.62052wk Low--EPS TTM83.21MFloat Cap5.600Historical HighLossP/E (Static)45.22MShs Float0.250Historical Low-0.01EPS LYR7.56%Amplitude--Dividend TTM25.21P/B1Lot Size--Div YieldTTM
MustGrow Biologics Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 11.50%-973.93K | -2.08%-931.37K | 90.95%-294.76K | 385.74%2.65M | -66.32%-932.26K | -11.81%-1.1M | -16.20%-912.39K | -35.07%-3.26M | -25.50%-927.57K | -13.57%-560.51K |
| Net income from continuing operations | 20.07%-960.21K | 1.14%-1.03M | 87.84%-676.94K | 442.48%3.43M | 12.80%-1.86M | 15.49%-1.2M | -3.64%-1.05M | -81.66%-5.57M | 8.56%-1M | -206.41%-2.13M |
| Remuneration paid in stock | -83.59%12.68K | 19.10%144.15K | -45.33%926.42K | -240.64%-290.6K | -7.97%1.02M | -55.51%77.26K | -41.62%121.03K | 525.73%1.69M | 266.59%206.62K | 884.22%1.11M |
| Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -80.92%10.07K | --0 | -2,059.66%-264.93K |
| Change In working capital | -212.32%-26.4K | -415.44%-41K | -190.15%-544.24K | -269.62%-489.62K | -112.48%-91.13K | 1,854.10%23.51K | 83.68%13K | 83.76%603.7K | -146.23%-132.47K | 853.67%730.43K |
| -Change in receivables | -127.57%-56.32K | -831.37%-29.42K | 70.11%-7.02K | -85.52%3.9K | 115.19%9.8K | -1,265.66%-24.75K | -66.41%4.02K | 24.28%-23.49K | 157.71%26.94K | -3,519.50%-64.53K |
| -Change in prepaid assets | -85.32%6.48K | 107.64%7.88K | 135.57%4.53K | 2,127.18%46.21K | -41.63%17.29K | 246.54%44.15K | -621.59%-103.12K | -253.37%-12.73K | 117.51%2.08K | 10.06%29.61K |
| -Change in payables and accrued expense | 1,205.14%53.56K | -117.35%-19.45K | 136.32%99.45K | 162.84%101.47K | 20.32%-118.22K | -84.61%4.1K | 1,093.53%112.1K | -177.95%-273.78K | -148.60%-161.48K | -410.39%-148.36K |
| -Change in other working capital | ---- | ---- | -170.18%-641.2K | ---- | ---- | ---- | ---- | --913.7K | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 11.50%-973.93K | -2.08%-931.37K | 90.95%-294.76K | 385.74%2.65M | -66.32%-932.26K | -11.81%-1.1M | -16.20%-912.39K | -35.07%-3.26M | -25.50%-927.57K | -13.57%-560.51K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -85.35%95.75K | 0 | -39.21%95.75K | -92.50%653.75K | 0 | -57.94%157.5K | ||||
| Proceeds from stock option exercised by employees | ---- | ---- | -85.35%95.75K | --0 | ---- | ---- | ---- | -69.35%653.75K | --0 | -57.94%157.5K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | -85.35%95.75K | --0 | -39.21%95.75K | ---- | ---- | -92.50%653.75K | --0 | -57.94%157.5K |
| Net cash flow | ||||||||||
| Beginning cash position | -3.57%5.89M | -2.84%6.82M | -27.07%7.02M | -47.55%4.17M | -40.06%5M | -34.59%6.1M | -27.07%7.02M | 190.39%9.62M | 158.97%7.94M | 161.93%8.35M |
| Current changes in cash | -10.42%-1.22M | -2.08%-931.37K | 92.36%-199.01K | 385.74%2.65M | -107.57%-836.51K | -11.81%-1.1M | -215.77%-912.39K | -141.28%-2.6M | -114.16%-927.57K | -238.37%-403.01K |
| End cash Position | -6.65%4.67M | -3.57%5.89M | -2.84%6.82M | -2.84%6.82M | -47.55%4.17M | -40.06%5M | -34.59%6.1M | -27.07%7.02M | -27.07%7.02M | 158.97%7.94M |
| Free cash from | 11.50%-973.93K | -2.08%-931.37K | 90.95%-294.76K | 385.74%2.65M | -66.32%-932.26K | -11.81%-1.1M | -16.20%-912.39K | -35.07%-3.26M | -25.50%-927.57K | -13.57%-560.51K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data